Iconix Biosciences, gene expression co., raises $4M
Iconix Biosciences, a Mountain View, Calif. gene expression profiling provider, has received $4 million in seventh round of funding from a research and licensing pact with Eli Lilly & Co., according to VentureWire (sub required):
Through the agreement with Lilly, Iconix may raise an additional $2 million through the deal whereby Lilly has access to Iconix’s data set, DrugMatrix, to test for a drug’s toxicity mechanism.
Peanut Butter redux, expensive Sonsini, Hoffman burned, Infinera & much more
(Updated) roundup of the high-stakes game going on in Silicon Valley:
Brad Garlinghouse’s Peanut Butter memo — The Yahoo executive complained about the company’s “proclivity to repeatedly hire leaders from outside.” This is noteworthy, because he himself was hired from the outside. Before Yahoo, he’d served as chief executive at DialPad, and drove that company into the ground. We reached out to Brad Monday night, and hope to get comment soon.
Larry Sonsini can’t be at fault — Fortune… Continue Reading